Expression of somatostatin receptor subtypes 1-5 in pancreatic islets of normoglycaemic and diabetic NOD mice

European Journal of Endocrinology

Volumn 153, Issue 3, 2005, Pages 445-454

  Ludvigsen, Eva ^a   Stridsberg, M ^a   Janson, E T ^a   Sandler, S ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PANCREAS POLYPEPTIDE; SOMATOSTATIN RECEPTOR 1; SOMATOSTATIN RECEPTOR 2; SOMATOSTATIN RECEPTOR 3; SOMATOSTATIN RECEPTOR 4; SOMATOSTATIN RECEPTOR 5;

AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; HOST RESISTANCE; HYPERGLYCEMIA; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INSULITIS; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; RISK FACTOR;

AGE FACTORS; ANIMALS; CELL COUNT; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOHISTOCHEMISTRY; ISLETS OF LANGERHANS; MALE; MICE; MICE, INBRED ICR; MICE, INBRED NOD; MICROSCOPY, FLUORESCENCE; PANCREATIC POLYPEPTIDE; RECEPTORS, SOMATOSTATIN; SEX FACTORS; TIME FACTORS;

EID: 26244432080     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.01986     Document Type: Article

References (31)

1. Atkinson MA & Leiter EH. The NODmouse model of type 1 diabetes: as good as it gets? Nature Medicine 1999 5 601-604.
2. Lampeter EF, Signore A, Gale EAM & Pozzilli P. Lessons from the Nod mouse for the pathogenesis and immunotherapy of human type-1 (insulin-dependent) diabetes-mellitus. Diabetologia 1989 32 703-708.
3. Leiter EH, Prochazka M & Coleman DL. The nonobese diabetic (Nod) mouse. American Journal of Pathology 1987 128 380-383.
4. Tochino Y. The NOD mouse as a model of type I diabetes. Critical Review of Immunology 1987 8 49-81.
5. Thomas HE & Kay TWH. Beta cell destruction in the development of autoimmune diabetes in the non-obese diabetic (NOD) mouse. Diabetes-Metabolism Research and Reviews 2000 16 251-261.
6. Yamada Y, Reisine T, Law SF, Ihara Y, Kubota A, Kagimoto S, Seino M, Seino Y, Bell GI & Seino S. Somatostatin receptors, an expanding gene family: cloning and functional characterization of human SSTR3, a protein coupled to adenylyl cyclase. Molecular Endocrinology 1992 6 2136-2142.
7. Yamada Y, Post SR, Wang K, Tager HS, Bell GI & Seino S. Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. PNAS 1992 89 251-255.
8. Yamada Y, Kagimoto S, Kubota A, Yasuda K, Masuda K, Someya Y, Ihara Y, Li O, Imura H, Seino S & Seino Y. Cloning, functional expression and pharmacological characterization of a fourth (hSSTR4) and a fifth (hSSTR5) human somatostatin receptor subtype. Biochemical and Biophysical Research Communication 1993 195 844-852.
9. Fehlmann D, Langenegger D, Schuepbach E, Siehler S, Feuerbach D & Hoyer D. Distribution and characterisation of somatostatin receptor mRNA and binding sites in the brain and periphery. Journal of Physiology (Paris) 2000 94 265-281.
10. Kulaksiz H, Eissele R, Rossler D, Schulz S, Hollt V, Cetin Y & Arnold R. Identification of somatostatin receptor subtypes 1, 2A, 3, and 5 in neuroendocrine tumours with subtype specific antibodies. Gut 2002 50 52-60.
11. Portela-Gomes GM, Stridsberg M, Grimelius L, Oberg K & Janson ET. Expression of the five different somatostatin receptor subtypes in endocrine cells of the pancreas. Applied Immunohistochemistry and Molecular Morphology 2000 8 126-132.
12. Reubi JC, Kappeler A, Waser B, Schonbrunn A & Laissue J. Immunohistochemical localization of somatostatin receptor sst2A in human pancreatic islets. Journal of Clinical Endocrinology and Metabolism 1998 83 3746-3749.
13. Raulf F, Perez J, Hoyer D & Bruns C. Differential expression of five somatostatin receptor subtypes, SSTR1-5, in the CNS and peripheral tissue. Digestion 1994 55 (Suppl 3) 46.
14. Koerker DJ, Ruch W, Chideckel E, Palmer J, Goodner CJ, Ensinck J & Gale CC. Somatostatin: hypothalamic inhibitor of the endocrine pancreas. Science 1974 184 482-484.
15. Kimura N, Schindler M, Kasai N & Kimura I. Immunohistochemical localization of somatostatin receptor type 2A in rat and human tissues. Endocrine Journal 2001 48 95-102.
16. Mitra SW, Mezey E, Hunyady B, Chamberlain L, Hayes E, Foor F, Wang Y, Schonbrunn A & Schaeffer JM. Colocalization of somatostatin receptor sst5 and insulin in rat pancreatic beta-cells. Endocrinology 1999 140 3790-3796.
17. Strowski MZ, Parmar RM, Blake AD & Schaeffer JM. Somatostatin inhibits insulin and glucagon secretion via two receptor subtypes: an in vitro study of pancreatic islets from somatostatin receptor 2 knockout mice. Endocrinology 2000 141 111-117.
18. Strowski MZ, Kohler M, Chen HY, Trumbauer ME, Li ZH, Szalkowski D, Gopal-Truter S, Fisher JK, Schaeffer JM, Blake AD, Zhang BB & Wilkinson HA Somatostatin receptor subtype 5 regulates insulin secretion and glucose homeostasis. Molecular Endocrinology 2003 17 93-106.
19. Cejvan K, Coy DH & Efendic S. Intra-islet somatostatin regulates glucagon release via type 2 somatostatin receptors in rats. Diabetes 2003 52 1176-1181.
20. Fagan SP, Azizzadeh A, Moldovan S, Ray MK, Adrian TE, Ding X, Coy DH & Brunicardi FC. Insulin secretion is inhibited by subtype five somatostatin receptor in the mouse. Surgery 1998 124 254-258.
21. Ludvigsen E, Olsson R, Stridsberg M, Janson ET & Sandler S. Expression and distribution of somatostatin receptor subtypes in the pancreatic islets of mice and rats. Journal of Histochemistry and Cytochemistry 2004 52 391-400.
22. Hunyady B, Hipkin RW, Schonbrunn A & Mezey E. Immunohistochemical localization of somatostatin receptor sst2A in the rat pancreas. Endocrinology 1997 138 2632-2635.
23. Li Z, Karlsson FA & Sandler S. Islet loss and alpha cell expansion in type 1 diabetes induced by multiple low-dose streptozotocin administration in mice. Journal of Endocrinology 2000 165 93-99.
24. Suarez-Pinzon W, Rajotte RV, Mosmann TR & Rabinovitch A. Both CD4 + and CD8 + T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction. Diabetes 1996 45 1350-1357.
25. Blum AM, Metwali A, Mathew RC, Cook G, Elliott D & Weinstock JV. Granuloma T lymphocytes in murine schistosomiasis mansoni have somatostatin receptors and respond to somatostatin with decreased IFN-gamma secretion. Journal of Immunology 1992 149 3621-3626.
26. Elliott DE, Li J, Blum AM, Metwali A, Patel YC & Weinstock JV. SSTR2A is the dominant somatostatin receptor subtype expressed by inflammatory cells, is widely expressed and directly regulates T cell IFN-gamma release. European Journal of Immunology 1999 29 2454-2463.
27. Eizirik DL, Sandler S & Palmer JP. Repair of pancreatic beta-cells. A relevant phenomenon in early IDDM? Diabetes 1993 42 1383-1391.
28. Buscail L, Esteve JP, Saint-Laurent N, Bertrand V, Reisine T, O'Carroll AM, Bell GI, Schally AV, Vaysse N & Susini C. Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms. PNAS 1995 92 1580-1584.
29. Cattaneo MG, Scita G & Vicentini LM. Somatostatin inhibits PDGF-stimulated Ras activation in human neuroblastoma cells. FEBS Letters 1999 459 64-68.
30. Cordelier P, Esteve JP, Bousquet C, Delesque N, O'Carroll AM, Schally AV, Vaysse N, Susini C & Buscail L. 1997 Characterization of the antiproliferative signal mediated by the somatostatin receptor subtype sst5. PNAS 94 9343-9348.
31. Zambre Y, Ling Z, Chen MC, Hou X, Woon CW, Culler M, Taylor JE, Coy DH, Van Schravendijk C, Schuit F, Pipeleers DG & Eizirik DL. 1999 Inhibition of human pancreatic islet insulin release by receptor-selective somatostatin analogs directed to somatostatin receptor subtype 5. Biochemical Pharmacology 1999 57 1159-1164.